<DOC>
	<DOCNO>NCT00396513</DOCNO>
	<brief_summary>The purpose study compare effect statin ( simvastatin ) metformin clinical ( menstrual cycle , excessive hair , skin problem ) , endocrine ( androgen ) , metabolic ( lipid , marker systemic inflammation ) , endothelial function parameter woman polycystic ovary syndrome ( PCOS ) .</brief_summary>
	<brief_title>Simvastatin Metformin Therapy PCOS Women . Prospective Randomised Trial .</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>PCO ESHRE/ASRM criterion : oligomenorrhea ( &lt; 8 spontaneus menses per year ) hyperandrogenism ( hirsutism acne ) hyperandrogenemia ( testosterone &gt; 70 ng/ml ) normal prolactin , TSH , 17OH progesterone evidence androgen produce malignancy , Cushing 's syndrome acromegaly age 1840 reliable use birth control pill least 3 month plan pregnancy elevate creatinine kinase 2 time upper limit normal liver enzyme ( transaminase ) 2 time upper limit normal use follow medication : cyclosporine , fibrates niacin , antifungal agent , macrolide antibiotic use oral contraceptive steroid hormone 3 month prior study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>PCOS</keyword>
	<keyword>Statin</keyword>
	<keyword>Metformin</keyword>
	<keyword>Testosterone</keyword>
	<keyword>Menstrual cycle</keyword>
	<keyword>Lipids</keyword>
</DOC>